The V920 Ebola Zaire vaccine (Ervebo, Merck) protects against Ebola virus disease caused by Zaire Ebola virus in at-risk adults aged 18 years or older.
Source: https://www.medscape.com/viewarticle/920068?nlid=132190_3901&src=wnl_newsalrt_191019_MSCPEDIT&uac=322450HY&impID=2135777&faf=1